natgillin/translations-raw huggingface dataset:
Because Pregabalin Accord is a generic medicine, studies in people have been limited to tests to determine that it is bioequivalent to the reference medicine, Lyrica.
Et Pregabalin Accord on geneeriline ravim, piirdusid patsiendiuuringud katsetega, milles näidati Pregabalin Accordi bioekvivalentsust võrdlusravimiga Lyrica.
Because Pregabalin Mylan is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Et Pregabalin Mylan on geneeriline ravim ja võrdlusravimiga bioekvivalentne, peetakse tema kasulikkust ja riske samadeks mis võrdlusravimil.
Because Pregabalin Mylan is a generic medicine, studies in people have been limited to tests to determine that it is bioequivalent to the reference medicine, Lyrica.
Et Pregabalin Mylan on geneeriline ravim, piirdusid patsiendiuuringud katsetega, milles näidati Pregabalin Mylani bioekvivalentsust võrdlusravimiga Lyrica.
Because Pregabalin Mylan Pharma is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Et Pregabalin Mylan Pharma on geneeriline ravim ja võrdlusravimiga bioekvivalentne, peetakse tema kasulikkust ja riske samadeks mis võrdlusravimil.
Because Pregabalin Mylan Pharma is a generic medicine, studies in people have been limited to tests to determine that it is bioequivalent to the reference medicine, Lyrica.
Et Pregabalin Mylan Pharma on geneeriline ravim, piirdusid patsiendiuuringud katsetega, milles näidati Pregabalin Mylan Pharma bioekvivalentsust võrdlusravimiga Lyrica.
Because Pregabalin Sandoz GmbH is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Et Pregabalin Sandoz GmbH on geneeriline ravim ja võrdlusravimiga bioekvivalentne, peetakse tema kasulikkust ja riske samadeks mis võrdlusravimil.
Because Pregabalin Sandoz is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Et Pregabalin Sandoz on geneeriline ravim ja võrdlusravimiga bioekvivalentne, peetakse tema kasulikkust ja riske samadeks mis võrdlusravimil.
Because Pregabalin Zentiva is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Et Pregabalin Zentiva on geneeriline ravim ja võrdlusravimiga bioekvivalentne, peetakse tema kasulikkust ja riske samadeks mis võrdlusravimil.
Because prostate cancer needs testosterone and other male hormones to survive and grow, by blocking these hormones, enzalutamide slows down the growth of the prostate cancer.
Et eesnäärmevähk vajab püsimiseks ja kasvuks testosterooni ja teisi meessuguhormoone, aeglustab ensalutamiid nende hormoonide blokeerimisega eesnäärmevähi kasvu.
Because Raloxifene Teva is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Et Raloxifene Teva on geneeriline ravim ja võrdlusravimiga bioekvivalentne, peetakse tema kasulikkust ja riske samadeks mis võrdlusravimil.
Because Rasagiline Mylan is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Et Rasagiline Mylan on geneeriline ravim ja võrdlusravimiga bioekvivalentne, peetakse tema kasulikkust ja riske samadeks mis võrdlusravimil.
Because renal elimination is the major elimination pathway, dose reduction in patients with renal impairment and dose supplementation following haemodialysis is necessary (see section 4.2 Table 1).
Et peamine eliminatsioon toimub neerude kaudu, on neerukahjustusega patsientidel vajalik annust vähendada ja hemodialüüsi järgselt anda täiendav annus (vt lõik 4.2 Tabel 1).
Because renal excretion is the primary route of elimination, dosage adjustment is necessary in patients with a creatinine clearance of 30-50 ml/min (see section 4.2).
Kuna väljutamine neerude kaudu on peamine eliminatsioonitee, on vajalik annuse korrigeerimine patsientidel, kelle kreatiniini kliirens on 30–50 ml/min (vt lõik 4.2).
Because Repaglinide Accord is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Et Repaglinide Accord on geneeriline ravim ja võrdlusravimiga bioekvivalentne, peetakse tema kasulikkust ja riske samadeks mis võrdlusravimil.
Because Repso is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Et Repso on geneeriline ravim ja võrdlusravimiga bioekvivalentne, peetakse tema kasulikkust ja riske samadeks mis võrdlusravimil.
Because Ribavirin Teva Pharma B.V. is a generic medicine and is bioequivalent to the reference medicine, its benefit and risk are taken as being the same as those of the reference medicine.
Et Ribavirin Teva Pharma B.V. on geneeriline ravim ja võrdlusravimiga bioekvivalentne, peetakse tema kasulikkust ja riske samadeks mis võrdlusravimil.
Because Ribavirin Teva Pharma B.V. is a generic medicine, studies have been limited to tests to determine that it is bioequivalent to the reference medicine.
Et Ribavirin Teva Pharma B.V. on geneeriline ravim, piirdusid uuringud katsetega, milles näidati ravimi bioekvivalentsust võrdlusravimiga.
Because Rivastigmine 3M Health Care Ltd is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Et Rivastigmine 3M Health Care Ltd on geneeriline ravim ja võrdlusravimiga bioekvivalentne, peetakse tema kasulikkust ja riske samadeks mis võrdlusravimil.
Because Rivastigmine Actavis is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Et Rivastigmine Actavis on geneeriline ravim ja võrdlusravimiga bioekvivalentne, peetakse tema kasulikkust ja riske samadeks mis võrdlusravimil.
Because RoActemra is given in one pre-filled syringe, it is unlikely that you will receive too much.
Kuna RoActemra’t manustatakse ühest süstlist, on ebatõenäoline, et saate liiga palju ravimit.
Because rotigotine enters your bloodstream through your skin, food or drink does not affect the way this medicine works.
Rotigotiin siseneb vereringesse läbi naha ning seetõttu ei mõjuta ravimi toimet toit või jook.
Because Sabervel is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Et Sabervel on geneeriline ravim ja võrdlusravimiga bioekvivalentne, peetakse tema kasulikkust ja riske samadeks mis võrdlusravimil.
Because safety and efficacy data from clinical trials are based upon administration with food, it is recommended that Targretin capsules be administered with food.
Kuna kliinilistes uuringutes saadud andmed ohutuse ja efektiivsuse kohta on kogutud Targretin’i võtmisel koos toiduga, on soovitatav, et Targretin’i kapsleid manustataks koos toiduga.
Because Sedadex is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Et Sedadex on geneeriline ravim ja võrdlusravimiga bioekvivalentne, peetakse tema kasulikkust ja riske samadeks mis võrdlusravimil.
Because Sepioglin is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Et Sepioglin on geneeriline ravim ja võrdlusravimiga bioekvivalentne, peetakse tema kasulikkust ja riske samadeks mis võrdlusravimil.
Because sevelamer binds bile acids, it may interfere with the absorption of fat soluble vitamins such as A, D, E and K.
Kuna sevelameer seob sapphappeid, võib see mõjutada rasvlahustuvate vitamiinide A, D, E ja K imendumist.
Because Sevohale is a generic medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Et Sevohale on geneeriline ravim, peetakse tema kasulikkust ja riske samadeks mis võrdlusravimil.
Because Sildenafil Actavis is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Et Sildenafil Actavis on geneeriline ravim ja võrdlusravimiga bioekvivalentne, peetakse tema kasulikkust ja riske samadeks mis võrdlusravimil.
Because Sildenafil Teva is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Et Sildenafil Teva on geneeriline ravim ja võrdlusravimiga bioekvivalentne, peetakse tema kasulikkust ja riske samadeks mis võrdlusravimil.
Because small increases in mean serum creatinine, blood urea nitrogen (BUN), and cystatin C were observed in the controlled study of nmDMD, it is recommended that serum creatinine, BUN, and cystatin C be monitored every 6 to 12 months in nmDMD patients receiving ataluren, or more frequently as needed based on the patient’s clinical status.
Et nmDMD kontrollitud uuringus täheldati seerumi keskmise kreatiniini, vere jääklämmastiku (BUN) ja tsüstatiin C tasemete väikest tõusu, on soovituslik iga 6 kuni 12 kuu järel või vastavalt patsiendi kliinilisele seisundile tihedamini kontrollida atalureeni saavate nmDMD patsientide seerumi kreatiniini, BUN-i ja tsüstatiin C taset.
Because symptoms of hepatitis B take a long time to develop, it is possible for unrecognised hepatitis B infection to be present at the time of vaccination.
Kuna B-hepatiidi sümptomid arenevad pikka aega, on võimalik, et vaktsineerimise ajal on juba olemas tuvastamata B-hepatiidi infektsioon.
Because symptoms of nighttime sleep disruption and daytime sleepiness are cyclical in patients with Non-24, with severity varying according to the state of alignment of the individual patient’s circadian rhythm with the 24-hour day (least severe when fully aligned, most severe when 12 hours out of alignment), efficacy endpoints for nighttime total sleep time and daytime nap duration were based on the 25% of nights with the least nighttime sleep, and the 25% of days with the most daytime nap time.
Et öiste unehäirete ja päevase unisuse sümptomid on mitte-24-tunnise une-ärkveloleku häirega patsientidel tsüklilised ja raskus oleneb konkreetse patsiendi ööpäevarütmi ühtlustumisest 24-tunnise ööpäevaga (vähem rasked täieliku ühtlustumise korral, kõige raskemad 12-tunnise nihke korral), põhinesid kogu öise uneaja ja päevase uinaku kestuse efektiivsuse tulemusnäitajad 25%-l kõige lühema uneajaga öödest ning 25%-l kõige pikema päevase uinakuajaga päevadest.
Because Tadalafil Mylan is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Et Tadalafil Mylan on geneeriline ravim ja võrdlusravimiga bioekvivalentne, peetakse tema kasulikkust ja riske samadeks mis võrdlusravimil.
Because talimogene laherparepvec is designed to enter and replicate in the tumour tissue, there could be a risk of foetal exposure to talimogene laherparepvec from tumour tissue that has crossed the placenta.
Talimogeenlaherparepvek on ette nähtud sisenema kasvajakoesse ja seal paljunema, mistõttu eksisteerib oht, et loode puutub talimogeenlaherparepvek’iga kokku platsentat läbinud kasvajakoe kaudu.
Because Telmisartan Actavis is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Et Telmisartan Actavis on geneeriline ravim ja võrdlusravimiga bioekvivalentne, peetakse tema kasulikkust ja riske samadeks mis võrdlusravimil.
Because Telmisartan Teva is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Et Telmisartan Teva on geneeriline ravim ja võrdlusravimiga bioekvivalentne, peetakse tema kasulikkust ja riske samadeks mis võrdlusravimil.
Because Telmisartan Teva Pharma is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Et Telmisartan Teva Pharma on geneeriline ravim ja võrdlusravimiga bioekvivalentne, peetakse tema kasulikkust ja riske samadeks mis võrdlusravimil.
Because Temozolomide Accord is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Et Temozolomide Accord on geneeriline ravim ja võrdlusravimiga bioekvivalentne, peetakse tema kasulikkust ja riske samadeks mis võrdlusravimil.
Because Temozolomide Hexal is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Et Temozolomide Hexal on geneeriline ravim ja võrdlusravimiga bioekvivalentne, peetakse tema kasulikkust ja riske samadeks mis võrdlusravimil.
Because Temozolomide Sandoz is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Et Temozolomide Sandoz on geneeriline ravim ja võrdlusravimiga bioekvivalentne, peetakse tema kasulikkust ja riske samadeks mis võrdlusravimil.
Because Temozolomide Sun is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Et Temozolomide Sun on geneeriline ravim ja bioekvivalentne võrdlusravimitega, peetakse tema kasulikkust ja riske samadeks mis võrdlusravimil.
Because teratogenic effects of rasburicase cannot be ruled out, Fasturtec should only be used during pregnancy if strictly necessary.
Rasburikaasi teratogeenset toimet ei saa välistada, mistõttu Fasturtec’i tohib raseduse ajal kasutada ainult range vajaduse korral.
Because testosterone is a male sex hormone, women who are taking Intrinsa should be monitored to see if they develop any ‘androgenic’ side effects (development of male characteristics) such as hair growth on the face, deepening of the voice or hair loss.
Et testosteroon on meessuguhormoon, tuleb Intrinsat kasutavaid naisi jälgida androgeensete kõrvalnähtude (mehelike omaduste kujunemine) tekkimise suhtes, näiteks karvakasv näol, hääle jämenemine, juuste väljalangemine.
Because testosterone is a male sex hormone, women who are taking Livensa should be monitored to see if they develop any ‘androgenic’ side effects (development of male characteristics) such as hair growth on the face, deepening of the voice or hair loss.
Et testosteroon on meessuguhormoon, tuleb Livensat kasutavaid naisi jälgida androgeensete kõrvalnähtude (mehelike omaduste kujunemine) tekkimise suhtes, näiteks karvakasv näol, hääle jämenemine, juuste väljalangemine.
Because the active substance used in HBVaxPro was already authorised for use in the EU, there have been no formal studies with HBVaxPro.
Et HBVaxPros toimeainena sisalduval ainel on juba Euroopa Liidus kasutamiseks müügiluba, ei ole HBVaxProga spetsiaalseid uuringuid tehtud.
Because the build-up of this fat in organs like the spleen, liver and bones is responsible for the symptoms of type-1 Gaucher disease, reducing its production helps prevent its build-up, and thereby helps the affected organs to function better.
Et glükosüültseramiidi ladestumine organitesse, nagu põrn, maks ja luud, põhjustab 1. tüüpi Gaucher’ tõve sümptomeid, aitab selle tekkimise vähendamine ennetada ladestumist ja kahjustatud organitel paremini töötada.
Because the cancer needs a supply of testosterone to survive and grow, by reducing the production of testosterone, abiraterone acetate may slow the growth of the prostate cancer.
Et vähk vajab ellujäämiseks ja kasvuks testosterooni, võib abirateroonatsetaat testosterooni tekkimise vähendamisega aeglustada eesnäärmevähi progresseerumist.
Because the clarithromycin active
kogus suurenes.
Because the disorder is variable in its expression, other organ system signs and symptoms not noted here may occur.
Kuna nimetatud häire väljendub erinevalt, võib esineda ka siin mainimata organsüsteemide nähte ja sümptomeid.
Because the dose of simvastatin should not exceed 10 mg daily in patients taking ciclosporin, the co-administration of Cholib with ciclosporin is contraindicated (see section 4.3).
Kuna simvastatiini päevane annus ei tohi ületada tsüklosporiini võtvate patsientide puhul 10 mg, on Cholib’i ja tsüklosporiini samaaegne manustamine vastunäidustatud (vt lõik 4.3).
Because the dose requirements in young children may not be stable and because they cannot express symptoms of hypoglycaemia, Ryzodeg is not suitable for children aged under 2 years.
Ryzodeg ei sobi alla 2- aastastele lastele, sest annuste nõuded väikelastel ei ole stabiilsed ja väikelapsed ei oska väljendada hüpoglükeemia sümptomeid.
Because the effect of EMEND on the pharmacokinetics of orally administered CYP3A4 substrates is greater than the effect of EMEND on the pharmacokinetics of intravenously administered CYP3A4 substrates, an interaction with orally administered chemotherapeutic medicinal products metabolised primarily or partly by CYP3A4 (e.g., etoposide, vinorelbine) cannot be excluded.
Kuna EMEND’i mõju suukaudselt manustatavate CYP3A4 substraatide farmakokineetikale on suurem kui intravenoosselt manustatavate CYP3A4 substraatide farmakokineetikale, ei saa välistada koostoimet suukaudselt manustatavate kemoterapeutikumidega, mis metaboliseeruvad põhiliselt või osaliselt CYP3A4 kaudu (nt etoposiid, vinorelbiin).
Because the effect of EMEND on the pharmacokinetics of orally administered CYP3A4 substrates is greater than the effect of EMEND on the pharmacokinetics of intravenously administered CYP3A4 substrates, an interaction with orally administered chemotherapeutic medicinal products metabolised primarily or partly by CYP3A4 (e.g., etoposide, vinorelbine) cannot be excluded.
Kuna EMEND’i mõju suukaudselt manustatavate CYP3A4 substraatide farmakokineetikale on suurem, kui intravenoosselt manustatavate CYP3A4 substraatide farmakokineetikale, siis koostoimet suukaudselt manustatud kemoterapeutikumidega, mis metaboliseeritakse põhiliselt või osaliselt CYP3A4 poolt (nt etoposiid, vinorelbiin) ei saa välistada.
Because the effects of Levodopa/Carbidopa/Entacapone Orion tablets are equivalent with entacapone 200 mg tablet administered concomitantly with the commercially available standard release carbidopa/levodopa preparations in corresponding doses these results are applicable to describe the effects of Levodopa/Carbidopa/Entacapone Orion as well.
Et Levodopa/Carbidopa/Entacapone Orion’i tablettide toimed on ekvivalentsed entakapooni 200 mg tablettidega, mida manustatakse samaaegselt ravimiturul saadaolevate standardselt vabanevate karbidopa/levodopa preparaatidega vastavates annustes, on need uuringute tulemused rakendatavad ka Levodopa/Carbidopa/Entacapone Orion’i toimete kirjeldamiseks.
Because the elimination of adalimumab may take up to four months, monitoring should be continued throughout this period.
Kuna adalimumabi eliminatsioon võib kesta kuni viis kuud, peab jälgimine jätkuma kogu selle perioodi kestel.
Because the elimination of certolizumab pegol may take up to 5 months, monitoring should be continued throughout this period (see section 4.3).
Kuna tsertolizumab pegooli eliminatsioon võib aega võtta kuni 5 kuud tuleb patsienti jälgida kogu selle perioodi vältel (vt lõik 4.3).
Because the formulations are not bioequivalent, neither the chewable tablets nor the granules for oral suspension should be substituted for the 400 mg tablet (see section 5.2).
400 mg tablette ei tohi asendada närimistablettide ega suukaudse suspensiooni graanulitega (vt lõik 5.2), sest preparaadid ei ole bioekvivalentsed.
Because the formulations are not bioequivalent, neither the granules for oral suspension nor the chewable tablets should be substituted for the 400 mg tablet (see section 5.2).
400 mg tablette ei tohi asendada suukaudse suspensiooni graanulite ega närimistablettidega, sest preparaadid ei ole bioekvivalentsed (vt lõik 5.2).
Because the frequency of gastrointestinal side effect with Diacomit, clobazam and valproate, such as anorexia, loss of appetite, vomiting, your child’s growth rate should be carefully monitored.
Kuna Diacomit, klobasaam ja valproaat võivad tihti tekitada kõrvalmõjusid seedeelundkonnas, näiteks isukaotust, anoreksiat ja oksendamist, tuleb teie lapse kasvukiirust hoolikalt jälgida.
Because the guanine analogue accumulates in T- cells and lasts longer in these cells, Atriance slows down the growth and multiplication of the cells involved in T-ALL and T-LBL.
Et guaniini analoog koguneb T-rakkudesse ja püsib neis rakkudes kauem, aeglustab Atriance T-rakulises ägedas lümfoblastses leukeemias ja T-rakulises lümfoblastses lümfoomis osalevate rakkude kasvu ja paljunemist.
Because the hepatitis B virus can become resistant to Hepsera, the doctor should only consider prescribing Hepsera if other treatments that are less likely to lead to resistance cannot be used; decompensated liver disease (when the liver is damaged and does not function normally.
Et B-hepatiidi virus võib muutuda Hepsera suhtes resistentseks, tohib arst määrata Hepserat ainult juhul, kui muid raviviise, mis tekitavad resistentsust vähem tõenäoliselt, ei saa kasutada; dekompenseeritud maksahaigusega patsientidel (maks on kahjustatud ning selle talitlus on häiritud).
Because the hepatitis B virus can become resistant to Zeffix, the doctor should only consider prescribing Zeffix if other treatments that are less likely to lead to resistance cannot be used; decompensated liver disease (when the liver does not work normally).
Et B-hepatiidi virus võib muutuda Zeffixi suhtes resistentseks, tuleb arstil määrata Zeffixit ainult juhul, kui muid raviviise, mis tekitavad vähem tõenäoliselt resistentsust, ei saa kasutada; dekompenseeritud maksahaigusega patsiendid (maksatalitlus on häiritud).
Because the INVEGA tablet is non-deformable and does not appreciably change shape in the gastrointestinal tract, INVEGA should not ordinarily be administered to patients with preexisting severe gastrointestinal narrowing (pathologic or iatrogenic) or in patients with dysphagia or significant difficulty in swallowing tablets.
Kuna INVEGA tablett ei deformeeru ning selle kuju seedetraktis oluliselt ei muutu, ei manustata INVEGA’t tavaliselt patsientidele, kellel on tõsine seedetrakti ahenemine (patoloogiline või iatrogeenne) või düsfaagia või oluliselt raskendatud tablettide neelamine.
Because the mechanism of action of pazopanib can severely affect organ growth and maturation during early post natal development in rodents (see section 5.3), pazopanib should not be given to paediatric patients younger than 2 years of age.
Pasopaniibi ei tohi anda alla 2-aastastele lastele, sest närilistel võib pasopaniib oma toimemehhanismi tõttu tõsiselt kahjustada organite kasvu ja küpsemist varajases postnataalses perioodis (vt lõik 5.3).
Because the number of patients in the European Union (EU) that undergo this type of conditioning and transplant is low, Tepadina was designated an ‘orphan medicine’ (a medicine used in rare diseases) on 29 January 2007.
Et sellist ettevalmistavat ravi ja siirdamist vajavate patsientide arv on Euroopa Liidus väike, nimetati Tepadina 29. jaanuaril 2007 harvikravimiks.
Because the number of patients that need mobilisation and collection of haematopoietic stem cells for transplantation is low, the condition is considered ‘rare’, and Mozobil was designated an ‘orphan medicine’ (a medicine used in rare diseases) on 20 October 2004.
Et siirdamise jaoks vereloome tüvirakkude mobiliseerimise ja kogumise vajadusega patsiente on vähe ning see seisund esineb harva, nimetati Mozobil 20. oktoobril 2004 harvikravimiks.
Because the number of patients who have angioedema is low, the disease is considered ‘rare’, and Firazyr was designated an ‘orphan medicine’ (a medicine used in rare diseases) on 17 February 2003.
Et angioödeemiga patsientide arv on väike ja see haigus esineb harva, nimetati Firazyr 17. veebruaril 2003 harvikravimiks.